
Biorestorative Therapies (BRTX) P/E Ratio
P/E Ratio as of Jun 16, 2025: -1.08
Average-1.15
Median-1.17
Minimum-1.33
Maximum-1.03
-1.08
Past Month+0.03 (2.70%)
The P/E ratio for Biorestorative Therapies (BRTX) is -1.08 as of Jun 16, 2025. This represents a decrease of -41.94% compared to its 12-month average P/E ratio of -1.86. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Biorestorative Therapies P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Biorestorative Therapies’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Biorestorative Therapies to industry peers.
Biorestorative Therapies P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Biorestorative Therapies’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Biorestorative Therapies to industry peers.
Biorestorative Therapies (BRTX) P/E Ratio Insights
See Biorestorative Therapies’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Biorestorative Therapies (BRTX)
Order type
Buy in
Order amount
Est. shares
0 shares
Biorestorative Therapies (BRTX) P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $1.80 | -1.20 |
May 1, 2025 | $1.78 | -1.48 |
Apr 1, 2025 | $1.78 | -1.48 |
Mar 3, 2025 | $1.51 | -2.11 |
Feb 3, 2025 | $2.36 | -3.30 |
Jan 2, 2025 | $1.49 | -2.09 |
Biorestorative Therapies (BRTX) End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -1.08 | -46.00% |
2024 | -2.00 | +376.19% |
2023 | -0.42 | +50.00% |
2022 | -0.28 | +133.33% |
2021 | -0.12 | -83.10% |
2020 | -0.71 | — |
FAQs About Biorestorative Therapies (BRTX) P/E ratio
The latest P/E ratio of Biorestorative Therapies (BRTX) is -1.08, as of Jun 16, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Biorestorative Therapies’s last 12-month average P/E ratio is -1.86, compared to its current P/E ratio of -1.08. This reflects a decrease of -41.94%.
Biorestorative Therapies’s current P/E ratio of -1.08 is lower than its last 12-month average P/E of -1.86. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Biorestorative Therapies’s average P/E ratio over the last 3 years is -1.01. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Biorestorative Therapies’s average P/E ratio over the last 5 years is -0.82. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.